Please assess the completion status of the following clinical trial:

Trial Title: Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically confirmed breast cancer~  * Stage I or II disease (T1-T2, N0, M0/MX disease)~    * No chest wall invasion by tumor (T3 disease)~* Medially or centrally located lesion~* No multicentric disease~  * Multifocal disease allowed~* No clinically positive axillary nodes~* No enlarged internal mammary nodes by CT scan~* Hormone receptor status not specified~PATIENT CHARACTERISTICS:~* Male or female~* Menopausal status not specified~* American Society of Anesthesiologists (ASA) physical status classification 1-2~* Not pregnant or nursing~* Negative pregnancy test~* No other concurrent known, invasive malignancy~* No known chronic pulmonary disease~* No known allergy to methylene blue or isosulfan blue~PRIOR CONCURRENT THERAPY:~* No prior thoracic or cardiac surgery~* No prior ipsilateral chest tube placement~  * Contralateral chest tube placement allowed~* No prior neoadjuvant chemotherapy~* No prior radiotherapy to the mediastinum

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Study Arms:
- Sentinel Lymph Node Biopsy (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).